Status:
COMPLETED
Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems
Lead Sponsor:
Societe dEtude, de Recherche et de Fabrication
Conditions:
Hip Arthropathy
Eligibility:
All Genders
18+ years
Brief Summary
This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. In order to reflect current practice, a comprehensive and conti...
Eligibility Criteria
Inclusion
- Patient over 18 years old at the time of surgery,
- Patient implanted with a SAGITTA EVL R revision femoral stem within its indications between 01/01/2016 and 31/12/2018,
- Affiliated to French health insurance system
Exclusion
- Patient who has not expressed consent for data collection and participation in the study,
- Patient unable to understand the surgeon's instructions or to perform postoperative follow-up.
- Patient with a contraindication to the use of the SAGITTA EVL R revision femoral stem
- Patient implanted with a SAGITTA EVL R revision femoral stem outside its indication
Key Trial Info
Start Date :
April 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 29 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06096168
Start Date
April 13 2023
End Date
October 29 2024
Last Update
June 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Rouen - Hôpital Charles Nicolle
Rouen, Seine Maritime, France, 76000